Citation Impact

Citing Papers

Predictive Effects of Circulating miR-221, miR-130a and miR-155 for Coronary Heart Disease: A Multi-Ethnic Study in China.
2017 Standout
Diverse functions of miR-125 family in different cell contexts
2013
Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR
2017
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
2013
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Clinical applications of the CellSearch platform in cancer patients
2018
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1
2017
Traditional Chinese medicine as a cancer treatment: Modern perspectives of ancient but advanced science
2019 Standout
Drug Resistance in Cancer: An Overview
2014 Standout

Works of Xiaoping Wan being referenced

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer
2013
Elevated STMN1 promotes tumor growth and invasion in endometrial carcinoma
2016
MicroRNA‐199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer‐initiating cells
2012
MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
2011
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing
2015
Rankless by CCL
2026